A Pivotal April for UBS: Shareholders Await Key Decisions on Capital and Leadership

UBS faces a pivotal April with its AGM, a key Swiss capital requirement decision, and Q1 earnings. Shareholders vote on a dividend hike and buyback as the stock faces pressure.

April has emerged as a critical month for UBS, packed with events that will shape the bank's strategic and regulatory future. While the period was anticipated to bring positive momentum, global market turbulence has instead pressured the stock. UBS shares have declined approximately 15% since the start of the year, trading just below their 200-day moving average. This weakness is attributed to a broader tariff shock that has particularly impacted financial institutions; peers Swiss Re and Zurich Insurance have seen similar declines due to their significant US exposure.

Shareholder Meeting and Capital Return in Focus

The chain of significant events begins with the Annual General Meeting scheduled for April 15 in Basel. Shareholders will vote on the board's proposal to raise the dividend to $1.10 per share, marking a substantial 22% increase from the previous year. This enhanced payout is to be complemented by a planned share buyback program worth $3 billion, set for 2026.

Concurrently, the bank's supervisory board is undergoing a notable reshuffle. Departing members Lukas Gähwiler, William C. Dudley, and Jeanette Wong will be replaced by three new nominees: Markus Ronner, Luca Maestri—the long-serving CFO of Apple—and Agustín Carstens, the former General Manager of the Bank for International Settlements. The appointment of Carstens is viewed as a strategic move to bolster regulatory expertise within the boardroom, a timely decision given pending regulatory developments.

The Looming Capital Requirement Decision

Running parallel to the AGM, the financial markets are keenly awaiting a decision from the Swiss Federal Council regarding stricter capital requirements for UBS. This proposed legislation is a direct consequence of the collapse of Credit Suisse. The initial government proposal could necessitate an additional $26 billion in capital. UBS has publicly opposed this plan, arguing that such unilateral requirements are not internationally coordinated and would structurally disadvantage the bank against its American competitors.

However, reports from the Financial Times suggest Swiss parliamentarians have signaled a potential compromise to UBS management. A key element under discussion involves allowing deferred tax assets to be counted towards capital, up to a limit of 10% of CET1 capital. This approach, compliant with Basel III rules, could significantly reduce the estimated burden from $10.8 billion to around $6.2 billion. The credibility of these political signals will become clearer as the month progresses.

First-Quarter Earnings to Cap the Month

The series of April milestones will conclude with the release of first-quarter financial results on April 29. The bank faces a high bar for comparison. For the full year 2025, UBS reported a net profit of $7.8 billion, representing a robust 53% year-on-year increase. Whether the current quarter can demonstrate similar strength amidst market disruptions caused by trade tensions will provide the next crucial assessment of the bank's operational resilience and the stock's near-term trajectory.